Clinical Trials Sponsored by Nelum+Corp

Total 905 results

Healthgen Biotechnology Corp.

Completed

A Study of OsrHSA in Adult Healthy Male and Female Volunteers

Ascites Hepatic

United States
Turnstone Biologics, Corp.

Completed

Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients

Non-Small Cell Lung Cancer

Canada
Universal Integrated Corp.

Completed

Study of the Efficacy and Safety of Quiklean® and Klean-Prep With Dulcolax® for the Bowel Preparation Prior to Colonoscopy

Bowel Preparation

Taiwan
Yu-Jay Corp.

Completed

Therapeutic Drug Monitoring Study of Reduced-Dose Efavirenz (400 mg) in Combo Tablet for Patients Receiving Atripla With Viral Suppression in Taiwan

HIV Infections

Taiwan
2C Tech Corp

Completed

Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal Diseases

Retinitis Pigmentosa

Mexico
PDS Biotechnology Corp.

Completed

An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101

High-risk HPV Infection and Biopsy-proven CIN1

United States
RXi Pharmaceuticals, Corp.

Unknown

Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts)

Plantar Warts | Common Warts | HPV (Human Papillomavirus) | Periungual Warts

United States
Sophiris Bio Corp

Completed

Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH (PLUS-1)

Benign Prostatic Hyperplasia

United States, Australia, Canada, Russian Federation, Ukraine, New Zealand
MAKO Surgical Corp.

Completed

Robotic Arm Assisted Total Knee Arthroplasty

Osteoarthritis | Rheumatoid Arthritis | Post-traumatic Arthritis

United States
Sophiris Bio Corp

Completed

Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate Cancer

Prostate Cancer

United Kingdom
Synta Pharmaceuticals Corp.

Terminated

A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC (Galaxy 2)

Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Non-Small-Cell Lung Adenocarcinoma

United States, France, Spain, Netherlands, Czech Republic, Serbia, Romania, Germany, Belgium, Italy, Hungary, United Kingdom, Canada, Poland, Bosnia and Herzegovina, Austria, Slovenia, Croatia, Russian Federation, Ukraine
Synta Pharmaceuticals Corp.

Terminated

Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer (GALAXY)

Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV

United States, Belgium, Bosnia and Herzegovina, Canada, Croatia, Czech Republic, Germany, Poland, Romania, Russian Federation, Serbia, Spain, United Kingdom
Synta Pharmaceuticals Corp.

Completed

A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC) (CHIARA)

Non Small Cell Lung Cancer

United States, Canada
RXi Pharmaceuticals, Corp.

Completed

Evaluation of Safety, PK, and Preliminary Effects on Scar Formation of Multiple Intradermal Administrations of RXI-109

Cicatrix | Scar Prevention
Synta Pharmaceuticals Corp.

Completed

A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

United States
Synta Pharmaceuticals Corp.

Terminated

Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma

Melanoma

United States, Spain, Canada, Australia, Germany, Puerto Rico, Romania, United Kingdom
Synta Pharmaceuticals Corp.

Completed

A Randomized, Double-blind, Placebo-controlled Clinical Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, Administered to Patients With Rheumatoid Arthritis to Determine Safety, Tolerability, Pharmacokinetic and Synovial Tissue Outcomes

Active, Moderate to Severe Rheumatoid Arthritis

Netherlands
Synta Pharmaceuticals Corp.

Unknown

Study Elesclomol Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia

Canada
Sophiris Bio Corp

Completed

Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

United States
Uptake Medical Corp

Completed

Bronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction (BTVA)

Chronic Obstructive Pulmonary Disease | Emphysema

Germany, Ireland, Australia, Austria
Biotie Therapies Corp.

Completed

BTT-1023 in Rheumatoid Arthritis

Rheumatoid Arthritis

Bulgaria
Biotie Therapies Corp.

Completed

Safety and Pharmacokinetics of ELB353 in Healthy Men

Healthy Volunteers

Germany
Synta Pharmaceuticals Corp.

Suspended

A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid Tumors

Metastatic Solid Tumors

United States
Synta Pharmaceuticals Corp.

Completed

STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors

Lymphoma | Leukemia | Hematological Malignancies | Metastatic or Unresectable Solid Tumors

United States
Medigreen Biotechnology Corp.

Unknown

Safety Study of Anti-Asthma Agent BMEC-1217B

Asthma

Taiwan
Etnova Therapeutics Corp.

Recruiting

A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma | Advanced Hepatocellular Carcinoma | Liver Cancer

Korea, Republic of
Aqualung Therapeutics Corp.

Not yet recruiting

Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS

Acute Respiratory Distress Syndrome (ARDS)
Synmosa Biopharma Corp.

Recruiting

Evaluate the Efficacy and Safety of Goofice® (Elobixibat) in Patients With Chronic Constipation

Constipation

Taiwan
GC Biopharma Corp

Recruiting

A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.

Hepatitis B

Korea, Republic of
Turnstone Biologics, Corp.

Recruiting

A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors (STARLING)

Breast Cancer | Colorectal Cancer | Non-Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Uveal Melanoma | Cutaneous Melanoma

United States, Canada
Angion Biomedica Corp

Not yet recruiting

Study to Assess the Safety and Tolerability of ANG-3070 in Subjects With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis (IPF)
Healthgen Biotechnology Corp.

Recruiting

Study of OsrhAAT or Placebo in Healthy Volunteers

Emphysema Secondary to Congenital AATD

United States
Healthgen Biotechnology Corp.

Recruiting

A Phase II Study of OsrHSA in Patients With Decompensated Cirrhotic Ascites

Cirrhotic Ascites

China
Sardocor Corp.
Covance

Recruiting

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction (MUSIC-HFrEF1)

Heart Failure | Congestive Heart Failure | Heart Failure, Systolic | HFrEF - Heart Failure With Reduced Ejection Fraction

United States
Chiesi Canada Corp

No longer available

Compassionate Use of Deferiprone in Patients With PKAN

Pantothenate Kinase-Associated Neurodegeneration
Angion Biomedica Corp

Completed

ANG-3070 in Healthy Adult Participants

Healthy Volunteers

Australia
Medicrea, USA Corp.

Withdrawn

Personalized Spine Study Group Registry

Degenerative Disc Disease | Spinal Stenosis | Spinal Fusion | Kyphoscoliosis | Scoliosis; Adolescence | Pseudoarthrosis of Spine | Kyphoses, Scheuermann
Mack Biotech, Corp.

Completed

Airway Clearance System (K031876) Phase IV Device Efficacy

Cystic Fibrosis, Pulmonary

United States
Universal Integrated Corp.

Completed

A Study of the Efficacy and Safety of Bowklean and Klean-Prep With Dulcolax for the Bowel Preparation Prior Colonoscopy

Bowel Preparation Before Colonoscopy

Taiwan
Response Biomedical Corp.

Completed

FLU A+B Nasal Swab Clinical Study (FLUA+B)

Influenza

United States, Canada
Sophiris Bio Corp

Completed

Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia (TRIUMPH-1)

Benign Prostatic Hyperplasia

Canada
Sophiris Bio Corp

Completed

PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer

Prostate Cancer

United States
RXi Pharmaceuticals, Corp.

Unknown

Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD

Age-related Macular Degeneration | Subfoveal Choroidal Neovascularization | Subretinal Scarring | Subretinal Fibrosis

United States
Ostar Meditech Corp

Completed

Assessment of the Clinical Efficacy of the Heart Spectrum Blood Pressure Monitor for Diagnosis of Atrial Fibrillation

Atrial Fibrillation
Uptake Medical Corp

Completed

Sequential Segmental Treatment of Emphysema With Upper Lobe Predominance (STEP-UP) Study

Emphysema

Australia, Ireland, Germany, Austria, New Zealand, United Kingdom
Response Biomedical Corp.

Completed

RAMP 200 / RAMP Cardiovascular Tests at the Point-of-Care (C-POC)

Myocardial Infarction | Heart Failure | Acute Coronary Syndrome | Congestive Heart Failure

United States
Synta Pharmaceuticals Corp.

Completed

Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors

Solid Tumors

United States
Synta Pharmaceuticals Corp.

Completed

STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma

Melanoma

United States
Synta Pharmaceuticals Corp.

Completed

A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors

United States
Synta Pharmaceuticals Corp.

Completed

A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer

Prostate Cancer

United States

Clinical Trials Sponsored by Nelum+Corp

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations